http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0167553-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc54b3d034bf3ca14bf9a0f18c492a51 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
| filingDate | 1984-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b57c33accd1c311ead5bef2ed1ca49 |
| publicationDate | 1986-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0167553-A1 |
| titleOfInvention | NEW THERAPEUTIC APPLICATION OF AN INDANE DIONE DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS FOR THIS USE. |
| abstract | The subject of the invention is the therapeutic use of an Indane dione derivative and the pharmaceutical compositions used for this use. The invention relates specifically to the use, as a lipid-lowering agent, of 2- AD (3, 4 - dimethoxybenzoyl) methyl BD 2-hydroxy 1, 3-dioxo indane of formula (I). The pharmaceutical compositions used for the use of the said compound contain from 50 to 200 mg of active principle in combination or in mixture with a pharmaceutical vehicle or excipient. |
| priorityDate | 1983-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.